SUSTAINED-RELEASE LITHIUM-CARBONATE IN A DOUBLE-BLIND-STUDY - SERUM LITHIUM LEVELS, SIDE-EFFECTS, AND PLACEBO RESPONSE

被引：27

作者：

MARINI, JL

SHEARD, MH

机构：

[1] CONNECTICUT MENTAL HLTH CTR,NEW HAVEN,CT

[2] YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06510

来源：

关键词：

D O I：

10.1002/j.1552-4604.1976.tb02405.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：276 / 283

页数：8

共 16 条

[1]

AMDISEN A, 1975, LITHIUM RES THERAPY, P197

[2]

BIRCH NJ, 1974, BRIT J CLIN PHARMACO, V1, pP339

[3]

BORG KO, 1974, ACTA PHARM SUEC, V11, P133

[4]

COPPEN A, 1969, J CLIN PHARMACOL N D, V9, P160

[5]

CRAMMER JL, 1974, BRIT MED J, V2, P650

[6]

FYRO B, 1970, Pharmacologia Clinica, V2, P236, DOI 10.1007/BF00404307

[7]

KERRY RJ, 1975, LITHIUM RES THERAPY, P148

[8]

Matussek N, 1971, Nervenarzt, V42, P376

[9]

OTTO U, 1972, ACTA PHARM SUEC, V9, P595

PERSSON, G .